FDA warns certain therapy to treat cancer may cause secondary cancer

ViewThe Food and Drug Administration is investigating the risks of CAR-T cell immunotherapies, which are used to treat certain forms of cancers like lymphoma and leukemia. 

The FDA says it has received reports of people getting T-cell malignancies, a type of cancer that originates in the white blood cells that are involved in...